Antioxidant Down-Regulates Interleukin-18 Expression in Asthma
@article{Lee2006AntioxidantDI,
title={Antioxidant Down-Regulates Interleukin-18 Expression in Asthma},
author={Kyung Sun Lee and So Ri Kim and Seoung Ju Park and Kyung Hoon Min and Ka Young Lee and Sun Mi Jin and Wan-Hee Yoo and Yong Chul Lee},
journal={Molecular Pharmacology},
year={2006},
volume={70},
pages={1184 - 1193}
}An alteration in the balance between a T-helper type 2 cell (Th2) response and a Th1 response may predispose to the development of bronchial asthma. Interleukin-18 (IL-18) has an ability to promote both Th1 and Th2 responses, depending on the surrounding cytokine environment. Reactive oxygen species (ROS) play a crucial role in the pathogenesis of airway inflammation and hyperresponsiveness. Recent studies have demonstrated that antioxidants are able to reduce airway inflammation and…
Figures from this paper
50 Citations
Administration of vitamin E attenuates airway inflammation through restoration of Nrf2 in a mouse model of asthma
- BiologyJournal of cellular and molecular medicine
- 2021
Vitamin E treatment may have the therapeutic potential through restoration of the Nrf2 level, especially in elderly asthma, as assessed using an eosinophilic asthma model.
Serum Interleukin-18 Expression in Children With Bronchial Asthma
- MedicineThe World Allergy Organization journal
- 2009
Serum IL-18 was found underexpressed in a group of asthmatic children especially during exacerbation and further studies are needed to outline its exact role in the pathogenesis of asthma.
Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics
- Biology, MedicinePharmaceuticals
- 2011
This article summarizes the latest research findings on the involvement of inflammatory changes, and mitochondrial dysfunction/oxidative stress in the development and progression of asthma, and the relationship between aging and age-related immunity in triggering asthma, the antioxidant therapeutic strategies in treating people with asthma.
L-2-Oxothiazolidine-4-Carboxylic Acid or α-Lipoic Acid Attenuates Airway Remodeling: Involvement of Nuclear Factor-κB (NF-κB), Nuclear Factor Erythroid 2p45-Related Factor-2 (Nrf2), and Hypoxia-Inducible Factor (HIF)
- BiologyInternational journal of molecular sciences
- 2012
It is demonstrated that OTC and LA can inhibit activation of NF-κB, Nrf2, and HIF, leading to attenuate allergen-induced airway remodeling, and down-regulated phosphoinositide 3-kinase activity and decreased phosphorylation of p38 mitogen-activated protein kinase but not extracellular signal-regulated kinase 1/2 or c-Jun N-terminal kinase.
Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma.
- Biology, MedicineThe Journal of allergy and clinical immunology
- 2010
Interleukin-18: a pro-inflammatory cytokine that plays an important role in acute pancreatitis
- Medicine, BiologyExpert opinion on therapeutic targets
- 2007
The use ofIL-18 antagonists as direct routes to block IL-18 activity and P2X7 receptor antagonists and interleukin-1β-converting enzyme (ICE) inhibitors as indirect routes to blocks IL-16 activity suggest that specific therapeutic inhibition of IL- 18 is a promising therapeutic approach for acute pancreatitis.
Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.
- Biology, MedicineAntioxidants & redox signaling
- 2012
Disruptions of redox signaling and control in asthma are discussed with a focus on the thiol, glutathione, and reduced (thiol) form (GSH).
IL-18 in induced sputum and airway hyperresponsiveness in mild asthmatics: effect of smoking.
- Medicine, BiologyRespiratory medicine
- 2009
Transforming growth factor β and severe asthma: a perfect storm.
- Biology, MedicineRespiratory medicine
- 2014
Interleukin‐18‐deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin‐induced asthma model
- Biology, MedicineClinical and experimental immunology
- 2008
It is suggested that IL‐18 may enhance chronic airway inflammation and airway remodelling through the production of IFN‐γ, IL‐13 and TGF‐β1 in the OVA‐induced asthma mouse model.
References
SHOWING 1-10 OF 71 REFERENCES
IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice.
- Biology, MedicineThe Journal of allergy and clinical immunology
- 2000
Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels.
- Biology, MedicineJournal of immunology
- 1998
Data show that, in vivo, the synergistic action of IL-12 and IL-18 is necessary to prevent Th2-like cell differentiation, and consequently inhibits the development of airway symptoms in a mouse model of allergic asthma.
Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L‐2‐ oxothiazolidine‐4‐carboxylic acid
- Biology, MedicineFASEB journal : official publication of the Federation of American Societies for Experimental Biology
- 2004
It is shown that the increased NF‐κB levels in nuclear protein extracts of lung tissues at 72 h after OVA inhalation were decreased by the administration of OTC, suggesting that OTC may reduce airway inflammation and hyper‐responsiveness through regulation of NF‐ KakB activity.
Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation1
- Biology, MedicineThe Journal of Immunology
- 2000
Data demonstrate that IL-18 may have multiple functions during an immune response that differ depending upon the local or systemic effects, and that neutralization ofIL-18 exacerbated, whereas exogenous IL- 18 had no effect on airway hyperreactivity.
A Small Molecule Inhibitor of Redox-Regulated NF-κB and Activator Protein-1 Transcription Blocks Allergic Airway Inflammation in a Mouse Asthma Model1
- Biology, ChemistryThe Journal of Immunology
- 2002
Results support redox-regulated transcription as a therapeutic target in asthma and demonstrate that selective inhibitors can reduce allergic airway inflammation and AHR.
α-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
- Biology, Medicine
- 2004
Airway epithelium expresses interleukin-18.
- Biology, MedicineThe European respiratory journal
- 1999
The expression of interleukin-18 within airway epithelium and the regulation of this cytokine under conditions of both T-helper1 and T- Helper2 cytokine production are demonstrated.
alpha-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.
- Biology, MedicineThe Journal of allergy and clinical immunology
- 2004
It is suggested that oxidative stress plays an important role in asthmatic airway inflammation and that alpha-lipoic acid may be useful as adjuvant therapy for bronchial asthma.
Interleukin-18 regulates both Th1 and Th2 responses.
- BiologyAnnual review of immunology
- 2001
IL-18 is a potent proinflammatory cytokine that has pathophysiological roles in several inflammatory conditions, and in principle, IL-18 enhances the IL-12-driven Th1 immune responses, but it can also stimulate Th2 immune responses in the absence of IL- 12.
IL-18 might reflect disease activity in mild and moderate asthma exacerbation.
- Medicine, BiologyThe Journal of allergy and clinical immunology
- 2001
It was suggested that IL-18 may play a potential role to activate immunologic responses and may reflect disease activity in mild and moderate asthma exacerbation.










